140 related articles for article (PubMed ID: 19721333)
21. Modulation of experimental mesangial proliferative nephritis by interferon-gamma.
Johnson RJ; Lombardi D; Eng E; Gordon K; Alpers CE; Pritzl P; Floege J; Young B; Pippin J; Couser WG
Kidney Int; 1995 Jan; 47(1):62-9. PubMed ID: 7731171
[TBL] [Abstract][Full Text] [Related]
22. Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis.
Ostendorf T; Kunter U; Gröne HJ; Bahlmann F; Kawachi H; Shimizu F; Koch KM; Janjic N; Floege J
J Am Soc Nephrol; 2001 May; 12(5):909-918. PubMed ID: 11316849
[TBL] [Abstract][Full Text] [Related]
23. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates proteinuria and acute mesangial injury induced by anti-Thy1.1 monoclonal antibody.
Wan Y; Gu L; Suzuki K; Karasawa T; Fujioka Y; Han GD; Koike H; Kawachi H; Shimizu F
Nephron Exp Nephrol; 2005; 99(4):e121-9. PubMed ID: 15722645
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme inhibition but not beta-adrenergic blockade limits transforming growth factor-beta overexpression in acute normotensive anti-thy1 glomerulonephritis.
Peters H; Rückert M; Gaedeke J; Liefeldt L; Ketteler M; Sharma AM; Neumayer HH
J Hypertens; 2003 Apr; 21(4):771-80. PubMed ID: 12658024
[TBL] [Abstract][Full Text] [Related]
25. Expression of CX3CL1/fractalkine by mesangial cells in vitro and in acute anti-Thy1 glomerulonephritis in rats.
Chen YM; Hu-Tsai MI; Lin SL; Tsai TJ; Hsieh BS
Nephrol Dial Transplant; 2003 Dec; 18(12):2505-14. PubMed ID: 14605272
[TBL] [Abstract][Full Text] [Related]
26. NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis.
Peters H; Daig U; Martini S; Rückert M; Schäper F; Liefeldt L; Krämer S; Neumayer HH
Kidney Int; 2003 Aug; 64(2):509-18. PubMed ID: 12846746
[TBL] [Abstract][Full Text] [Related]
27. Specific inhibition of Egr-1 prevents mesangial cell hypercellularity in experimental nephritis.
Carl M; Akagi Y; Weidner S; Isaka Y; Imai E; Rupprecht HD
Kidney Int; 2003 Apr; 63(4):1302-12. PubMed ID: 12631347
[TBL] [Abstract][Full Text] [Related]
28. Platelet inhibition limits TGF-beta overexpression and matrix expansion after induction of anti-thy1 glomerulonephritis.
Peters H; Eisenberg R; Daig U; Liefeldt L; Westenfeld R; Gaedeke J; Krämer S; Neumayer HH
Kidney Int; 2004 Jun; 65(6):2238-48. PubMed ID: 15149337
[TBL] [Abstract][Full Text] [Related]
29. Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis.
Hartner A; Hilgers KF; Bitzer M; Veelken R; Schöcklmann HO
J Mol Med (Berl); 2003 Jan; 81(1):32-42. PubMed ID: 12545247
[TBL] [Abstract][Full Text] [Related]
30. Retinoic acid reduces glomerular injury in a rat model of glomerular damage.
Wagner J; Dechow C; Morath C; Lehrke I; Amann K; Waldherr R; Floege J; Ritz E
J Am Soc Nephrol; 2000 Aug; 11(8):1479-1487. PubMed ID: 10906161
[TBL] [Abstract][Full Text] [Related]
31. Benidipine, a long-acting calcium-channel blocker, prevents the progression to end-stage renal failure in a rat mesangioproliferative glomerulonephritis.
Nakamura T; Obata JE; Onitsuka M; Shimada Y; Yoshida Y; Kawachi H; Shimizu F
Nephron; 2000 Nov; 86(3):315-26. PubMed ID: 11096289
[TBL] [Abstract][Full Text] [Related]
32. Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis.
Ostendorf T; Rong S; Boor P; Wiedemann S; Kunter U; Haubold U; van Roeyen CR; Eitner F; Kawachi H; Starling G; Alvarez E; Smithson G; Floege J
J Am Soc Nephrol; 2006 Apr; 17(4):1054-62. PubMed ID: 16510766
[TBL] [Abstract][Full Text] [Related]
33. Usp2-69 overexpression slows down the progression of rat anti-Thy1.1 nephritis.
Mao X; Luo W; Sun J; Yang N; Zhang LW; Zhao Z; Zhang Z; Wu H
Exp Mol Pathol; 2016 Oct; 101(2):249-258. PubMed ID: 27640956
[TBL] [Abstract][Full Text] [Related]
34. Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activation.
Daniel C; Wagner A; Hohenstein B; Hugo C
Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1299-309. PubMed ID: 19726547
[TBL] [Abstract][Full Text] [Related]
35. Nicorandil suppresses urinary protein excretion and activates eNOS in Dahl salt-sensitive hypertensive rats.
Tashiro Y; Yogo K; Serizawa K; Endo K
Clin Exp Nephrol; 2015 Jun; 19(3):343-9. PubMed ID: 24952900
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of matrix metalloproteinases attenuates anti-Thy1.1 nephritis.
Steinmann-Niggli K; Ziswiler R; Küng M; Marti HP
J Am Soc Nephrol; 1998 Mar; 9(3):397-407. PubMed ID: 9513901
[TBL] [Abstract][Full Text] [Related]
37. PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis.
Gilbert RE; Kelly DJ; McKay T; Chadban S; Hill PA; Cooper ME; Atkins RC; Nikolic-Paterson DJ
Kidney Int; 2001 Apr; 59(4):1324-32. PubMed ID: 11260393
[TBL] [Abstract][Full Text] [Related]
38. A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis.
Ostendorf T; van Roeyen CR; Peterson JD; Kunter U; Eitner F; Hamad AJ; Chan G; Jia XC; Macaluso J; Gazit-Bornstein G; Keyt BA; Lichenstein HS; LaRochelle WJ; Floege J
J Am Soc Nephrol; 2003 Sep; 14(9):2237-47. PubMed ID: 12937299
[TBL] [Abstract][Full Text] [Related]
39. Protein kinase C β inhibition ameliorates experimental mesangial proliferative glomerulonephritis.
Tokuyama H; Kim S; Zhang Y; Langham RG; Cox AJ; Gow RM; Kelly DJ; Gilbert RE
Nephrology (Carlton); 2011 Sep; 16(7):649-55. PubMed ID: 21575103
[TBL] [Abstract][Full Text] [Related]
40. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative.
Daniel C; Ziswiler R; Frey B; Pfister M; Marti HP
Exp Nephrol; 2000; 8(1):52-62. PubMed ID: 10644883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
